Boston, 15 - 16 September 2025

Aiva Simaite to present the latest LAI developments within InnoCore

Meet InnoCore Pharmaceuticals at the DDF Summit in Boston – Unlock the Potential of Long-Acting Injectables for your API

Our Chief Business Officer, Martin Bakker and Project Manager, Aiva Simaite, will be attending the Drug Delivery and Formulation Summit in Boston, where we’ll be showcasing our latest advancements in biodegradable long-acting injectable (LAI) technologies.

Join our presentation

Our expert Aiva Simaite will go into detail during her presentation on how InnoCore’s SynBiosys® polymer platform enables sustained release of peptides and biologics—without the common limitations of PLGA, such as aggregation, acylation, or high local pH.

Arrange a meeting

We would love to discuss how our drug delivery technologies can support your development goals. Please visit us at our booth #26, reach out to us directly through the contact form below, or contact us on: +31 50 575 3100

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Aiva Simaite - Innocore Team Member
Aiva
Program Manager
“"Sustained release technologies for peptides and biologics are redefining therapeutic possibilities — enabling longer efficacy, better patient adherence, and more precise control over complex molecules. I'm excited to present our latest advances that bring us closer to better, more effective drug delivery systems."”
Meet Aiva
Related insights
Boston, 15 - 16 September 2025
Drug Delivery & Formulation Summit – Boston
Our expert Aiva Simaite is eager to present at the DDF Summit in Boston!
Read the full story
Vienna, 3 - 5 November 2025
BioEurope – Vienna
Meet us at the BioEurope in Vienna from 3 - 5 November! Let’s build the future of Biologics and Peptides together.
Read the full story
Weiging polymer or microparticles at InnoCore
01 December 2024 | Innovation & Research
Award of EU grant and Joins Research Consortium focused in brain diseases
Innocore has been awarded an EU grant and Joins Research Consortium focused in brain diseases withh argeted drug delivery across the blood-brain barrier.
Read the full story